Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint may contribute to the pathophysiology and clinical symptoms.
Arjen Blom (photo up), theme Inflammatory diseases will focus on the involvement of the alarmins S100A8 and -A9 in pain behavior during experimental osteoarthritis (OA). The sequence of events that leads to pain via alarmins will be studied both in experimental OA and in a human trial.
The group of Peter van Lent has significantly contributed in understanding the role of alarmins S100A8/A9 in inflammation and joint destruction in osteoarthritis.
Related news items
Ignacio Malagon, first professor of Pediatric Anaesthesiology in the Netherlands21 January 2019
Ignacio Malagon has been appointed professor of Pediatric Anaesthesiology at Radboud University / Radboud university medical center with effect from 1 January 2019. He is the first professor in this field in the Netherlands.read more
Quickly detecting actual heart attacks prevents unnecessary hospital visits Research by Radboud university medical center improves efficacy and reduces cost of cardiac care4 January 2019
Many patients who suffer from chest pain are not actually having a heart attack, making an emergency hospital visit unnecessary. Is there a way to quickly and accurately determine at home whether emergency hospital treatment is necessary?read more
Radboud university medical center treats metastatic liver cancer with holmium microspheres MRI imaging during surgery can improve the outcome4 January 2019
For the first time Radboud university medical center has treated a patient with liver metastases by using holmium radio-embolization. With this technique, radioactive holmium microspheres are injected via a catheter into the liver artery.read more
Research into drugs for treating rare diseases can be more efficient and patient-oriented18 December 2018
To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).read more